Brand/Generic Settlements To Be Subject Of Senate Judiciary Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA is among the parties scheduled to testify at the panel next week, which could coincide with the reintroduction of Sen. Kohl’s bill to curb settlements.